Literature DB >> 24942881

Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.

Carolyn M Gray1, Kelly A McCorkell1, Srinivas K Chunduru2, Mark A McKinlay3, Michael J May4.   

Abstract

Non-canonical NF-κB signaling is controlled by the precise regulation of NF-κB inducing kinase (NIK) stability. NIK is constitutively ubiquitylated by cellular inhibitor of apoptosis (cIAP) proteins 1 and 2, leading to its complete proteasomal degradation in resting cells. Following stimulation, cIAP-mediated ubiquitylation of NIK ceases and NIK is stabilized, allowing for inhibitor of κB kinase (IKK)α activation and non-canonical NF-κB signaling. Non-canonical NF-κB signaling is terminated by feedback phosphorylation of NIK by IKKα that promotes NIK degradation; however, the mechanism of active NIK protein turnover remains unknown. To address this question, we established a strategy to precisely distinguish between basal degradation of newly synthesized endogenous NIK and induced active NIK in stimulated cells. Using this approach, we found that IKKα-mediated degradation of signal-induced activated NIK occurs through the proteasome. To determine whether cIAP1 or cIAP2 play a role in active NIK turnover, we utilized a Smac mimetic (GT13072), which promotes degradation of these E3 ubiquitin ligases. As expected, GT13072 stabilized NIK in resting cells. However, loss of the cIAPs did not inhibit proteasome-dependent turnover of signal-induced NIK showing that unlike the basal regulatory mechanism, active NIK turnover is independent of cIAP1 and cIAP2. Our results therefore establish that the negative feedback control of IKKα-mediated NIK turnover occurs via a novel proteasome-dependent and cIAP-independent mechanism.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bortezomib; NF-κB; NIK; Proteasome; Smac mimetic; cIAP

Mesh:

Substances:

Year:  2014        PMID: 24942881      PMCID: PMC4107106          DOI: 10.1016/j.bbrc.2014.05.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  20S proteasomes and protein degradation "by default".

Authors:  Gad Asher; Nina Reuven; Yosef Shaul
Journal:  Bioessays       Date:  2006-08       Impact factor: 4.345

Review 2.  Targeting of substrates to the 26S proteasome.

Authors:  C M Pickart
Journal:  FASEB J       Date:  1997-11       Impact factor: 5.191

3.  The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.

Authors:  Emmanuel Dejardin; Nathalie M Droin; Mireille Delhase; Elvira Haas; Yixue Cao; Constantin Makris; Zhi-Wei Li; Michael Karin; Carl F Ware; Douglas R Green
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

4.  Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

5.  Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.

Authors:  Gongxian Liao; Minying Zhang; Edward W Harhaj; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

6.  IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

Authors:  Eugene Varfolomeev; John W Blankenship; Sarah M Wayson; Anna V Fedorova; Nobuhiko Kayagaki; Parie Garg; Kerry Zobel; Jasmin N Dynek; Linda O Elliott; Heidi J A Wallweber; John A Flygare; Wayne J Fairbrother; Kurt Deshayes; Vishva M Dixit; Domagoj Vucic
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

7.  Noncanonical NF-κB signaling is limited by classical NF-κB activity.

Authors:  Carolyn M Gray; Caroline Remouchamps; Kelly A McCorkell; Laura A Solt; Emmanuel Dejardin; Jordan S Orange; Michael J May
Journal:  Sci Signal       Date:  2014-02-04       Impact factor: 8.192

8.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

Authors:  Jonathan J Keats; Rafael Fonseca; Marta Chesi; Roelandt Schop; Angela Baker; Wee-Joo Chng; Scott Van Wier; Rodger Tiedemann; Chang-Xin Shi; Michael Sebag; Esteban Braggio; Travis Henry; Yuan-Xiao Zhu; Homer Fogle; Tammy Price-Troska; Gregory Ahmann; Catherine Mancini; Leslie A Brents; Shaji Kumar; Philip Greipp; Angela Dispenzieri; Barb Bryant; George Mulligan; Laurakay Bruhn; Michael Barrett; Riccardo Valdez; Jeff Trent; A Keith Stewart; John Carpten; P Leif Bergsagel
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

10.  Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.

Authors:  A Matsushima; T Kaisho; P D Rennert; H Nakano; K Kurosawa; D Uchida; K Takeda; S Akira; M Matsumoto
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  5 in total

1.  Lymph node formation and B cell homeostasis require IKK-α in distinct endothelial cell-derived compartments.

Authors:  Kelly A McCorkell; Nipun Jayachandran; Michelle D Cully; Jacquelyn Freund-Brown; Tiffany Weinkopff; James Monslow; Yinling Hu; Ellen Puré; Bruce D Freedman; Jorge I Alvarez; Michael P Cancro; Michael J May
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

Review 2.  NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis.

Authors:  Bingran Wang; Jun Shen
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 3.  Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?

Authors:  Ae R Noort; Paul P Tak; Sander W Tas
Journal:  Arthritis Res Ther       Date:  2015-01-28       Impact factor: 5.156

4.  cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs.

Authors:  Joanna Z Kawalkowska; Joy Ogbechi; Patrick J Venables; Richard O Williams
Journal:  Sci Adv       Date:  2019-05-01       Impact factor: 14.136

5.  A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling.

Authors:  Kislay Parvatiyar; Jose Pindado; Anurupa Dev; Saba Roghiyh Aliyari; Shivam A Zaver; Hoda Gerami; Maxime Chapon; Amir A Ghaffari; Anant Dhingra; Genhong Cheng
Journal:  Nat Commun       Date:  2018-07-17       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.